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Background: To solve the efficiency versus cytotoxicity and tumor-targeting problems of 
polyethylenimine (PEI) used as a nonviral gene delivery vector, a degradable PEI derivate 
coupled to a bifunctional peptide R13 was developed.
Methods: First, we synthesized a degradable PEI derivate by crosslinking low-molecular-weight 
PEI with pluronic P123, then used tumor-targeting peptide arginine-glycine-aspartate-cysteine 
(RGDC), in conjunction with the cell-penetrating peptide Tat (49–57), to yield a bifunctional 
peptide RGDC-Tat (49–57) named R13, which can improve cell selection and increase cellular 
uptake, and, lastly, adopted R13 to modify the PEI derivates so as to prepare a new polymeric 
gene vector (P123-PEI-R13). The new gene vector was characterized in terms of its chemical 
structure and biophysical parameters. We also investigated the specificity, cytotoxicity, and 
gene transfection efficiency of this vector in αvβ3-positive human cervical carcinoma Hela 
cells and murine melanoma B16 cells in vitro.
Results: The vector showed controlled degradation, strong targeting specificity to αvβ3   receptor, 
and noncytotoxicity in Hela cells and B16 cells at higher doses, in contrast to PEI 25 KDa. 
The particle size of P123-PEI-R13/DNA complexes was around 100–250 nm, with proper zeta 
potential. The nanoparticles can protect plasmid DNA from being digested by DNase I at a 
concentration of 6 U DNase I/µg DNA. The nanoparticles were resistant to dissociation induced 
by 50% fetal bovine serum and 600 µg/mL sodium heparin. P123-PEI-R13 also revealed higher 
transfection efficiency in two cell lines as compared with PEI 25 KDa.
Conclusion: P123-PEI-R13 is a potential candidate as a safe and efficient gene-delivery   carrier 
for gene therapy.
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Introduction
Cancer is a scourge of the human race. Its classical treatments such as surgery, 
  chemotherapy, and radiotherapy are still insufficiently effective in many cases; thus, new 
anticancer strategies are urgently required.1 Gene therapy provides a   promising tool to 
eradicate this disease by treating it at its source. The key to gene therapy is finding an 
ideal gene-delivery vector. Delivery of nucleic acids into cells using   cationic polymers 
has recently attracted remarkable interest in the field of nonviral gene therapy, due to 
their structural diversity, easy production, nonimmunogenicity, and safety.2 One of 
the most effective and widely studied synthetic nonviral   gene-delivery vectors is the 
polycation polyethylenimine (PEI), which has recently been employed for the design 
of DNA-delivery vehicles. By adding this cationic polymer to DNA, the condensed 
complexes can be spontaneously formed through electrostatic   interactions,   resulting in 
efficient transport of intact DNA into the nucleus.3–5 Gene delivery using PEI involves 
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condensation of DNA into compact particles, uptake into 
the cells, release from the endosomal compartment into the 
cytoplasm, and uptake of the DNA into the nucleus. The 
high transfection efficiency of PEI/DNA complexes should 
be ascribed to the “proton sponge” effect of PEI.6,7 How-
ever, polyplexes of PEI/DNA have shown two outstanding 
problems. First of all, long PEI chains are highly effective 
in gene transfection but are cytotoxic. Conversely, short PEI 
chains display lower cytotoxicity but lower efficiency.8 The 
major drawback with gene delivery using PEI is the lack of 
satisfactory specificity toward tumor cells, because there is no 
binding selectivity between the positively charged polycation 
and the negatively charged body cells.9
Pluronic block copolymers, which consist of hydrophilic 
ethylene oxide (EO) and hydrophobic propylene oxide (PO) 
blocks arranged in a basic A-B-A structure (EO x -PO y -EO 
x), are amphiphilic molecules that can be used as structural 
elements of the polycation-based gene-delivery systems.10 
Kabanov et al10–13 previously reported that pluronic can 
enhance cell interactions, DNA transport, and transgene 
expression, and possesses the unique ability to be incorpo-
rated into cell membranes as a result of the presence of the 
hydrophobic poly-PO chain. In contrast, hydrophilic EO 
chains do not interact with lipid membranes but can be used 
to prevent binding of other polymers with the membranes.10 
The systems are stabilized in dispersion by the EO corona in 
a manner similar to regular pluronic micelles. The micelles 
of these copolymers are sufficiently potent in the ability to 
bind cellular membrane, and a relatively high concentration 
of micelles can be reached in solution.14 Among these copo-
lymers, pluronic notation P123 with formula EO20-PO70-
EO20 exhibits higher stability in terms of critical micelle 
concentration.15 In this paper we link low-molecular-weight 
PEI (LMW PEI) with P123 by chemical crosslinking to 
obtain cladodromous or cancellated PEI derivates with high 
molecular weight, which can guarantee higher transfection 
efficiency and degrade into lower-cytotoxic LMW PEI 
because of crosslinked chemical bond cleavage by hydroly-
sis after uptake into the cells. Hence, this makes it possible 
to greatly reduce the cytotoxicity of PEI on the premise of 
ensuring higher transfection efficiency and thereby solves the 
“catch 22” problem of efficiency versus cytotoxicity.
Receptor-mediated tumor targeting is another   increasingly 
important research field of nonviral gene-delivery systems. 
Integrins are a family of transmembrane glycoproteins with 
relatively small cytoplasmic domains. They consist of two 
subunits, α and β. Generally, as receptors, an individual 
integrin may recognize several distinct proteins. Among 
the integrins, the αvβ3 receptor is involved in tumor cell 
migration and angiogenesis. The αvβ3 receptors are highly 
expressed on tumor cells and tumor angiogenic blood vessels, 
whereas they are not detectable on quiescent blood vessels. 
Thus, the αvβ3 integrin participates in tumor metastasis and 
tumor-related   angiogenesis.16 The highly selective expres-
sion of αvβ3 integrin in the neovascular tissue and various 
tumors allows its use as a suitable target. Arginine-glycine-
aspartate (RGD) peptide is a key binding moiety that has 
been shown to bind specifically to αvβ3 integrin receptors.17 
Cell-penetrating peptides (CPPs) are 7–30 amino acid long 
peptides capable of translocating various macromolecules 
across the plasma membrane and targeting to the cell nucleus. 
CPPs have been applied to gene delivery. Kilk et al18 demon-
strated that CPP transportan 10 (TP10) could enhance PEI-
mediated transfection at relatively low concentrations and 
help to develop future gene-delivery systems with reduced 
  toxicity. The HIV Tat-derived peptide is a small basic peptide 
for successfully delivering a large variety of cargoes into 
cells such as nanoparticles, proteins, and nucleic acids. The 
transduction domain or region conveying CPPs appears to 
be confined to a small stretch of basic amino acids with the 
sequence RKKRRQRRR and is known as Tat (49–57).19,20 
Therefore, we have used a linear RGD peptide, RGDC, in 
conjunction with Tat (49–57) to yield a new chimeric peptide, 
RGDC-Tat (49–57), named R13. The bifunctional R13 can 
target to αvβ3 receptors expressed abundantly on tumor cells 
and carry cargo molecules inside the cells. Adopting R13 to 
modify PEI derivates can improve cell selection, promote 
cargo transport, and enhance   transfection efficiency.
Above all, in this work, we first linked LMW PEI with 
P123 to obtain degradable PEI derivates with high molecular 
weight, then used tumor-targeting peptide RGD, in conjunction 
with the CPP Tat (49–57) to yield a bifunctional peptide R13, 
and, lastly, adopted R13 to modify the PEI derivates so as to 
prepare a new nonviral gene delivery vector (P123-PEI-R13). 
The new gene vector was characterized in terms of its chemical 
structure and biophysical parameters. We also investigated the 
specificity, cytotoxicity, and gene transfection efficiency of 
this vector in αvβ3-positive human cervical carcinoma Hela 
cells and murine melanoma B16 cells in vitro. The purpose of 
the present study was to reduce cytotoxicity of PEI, improve 
its tumor targeting, and increase cellular uptake of genes, 
enhancing the therapeutic effect of gene therapy on cancer.
Materials and methods
Materials
Branched PEI (MW 2000), fluorescein isothiocyanate 
(FITC), N-succinimidyl-4-(N-maleimido-methyl) cyclo-
hexane-1-carboxylate (SMCC), horseradish peroxidase 
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(HRP), heparin, and 3-(4, 5-dimethylthiazol-2-yl)-2, 
5-diphenyl tetrazolium bromide (MTT) were obtained from 
Sigma-Aldrich (St Louis, MO). P123 was kindly provided 
by BASF Corporation (Mount Olive, NJ). DNase I was 
purchased from the Worthington Company (Lakewood, 
NJ). RPMI 1640 culture medium and fetal bovine serum 
(FBS) were purchased from Invitrogen (Carlsbad, CA). 
Luciferase assay system for in vitro transfection assay and 
pGL-3 control vector with SC-40 promoter and enhancer 
encoding firefly (Photinus pyralis) luciferase were obtained 
by Promega (Madison, WI). The plasmid encoding the 
enhanced green fluorescent protein (pEGFP-N2) was kindly 
provided by the Institute of Life Science and Technology 
of  Tongji University (Shanghai, People’s Republic of 
China). The plasmids were amplified using Escherichia coli 
DH5α and prepared using the Qiagen End-free Plasmid 
Mega Kit (Qiagen GmbH, Hilden, Germany). The purity 
of the purified and concentrated DNA was determined 
by measuring its ultraviolet absorbance at 260 nm and 
280 nm respectively. The oligopeptide Arg-Gly-Asp-
Cys-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg (R13, MW 
1771.10 Da) was synthesized by GL Biochem (  Shanghai, 
China), and the amino acid sequence was confirmed by 
mass spectroscopy.
Binding of R13 to integrin receptor
Integrin αvβ3 receptors are highly expressed on Hela cells 
and B16 cells and almost not expressed on MCF-7 cells. 
Three kinds of cells were cultivated under standard condi-
tions at 37°C in a humidified 95% air/5% CO2 atmosphere 
in RPMI 1640 in the presence of 10% FBS. Before the 
experiment, the cells were trypsinized and centrifuged to 
remove culture medium, and then 1% bovine serum albumin 
solution was added to block the protein-binding site. After 
incubation for 20 minutes, the cells were centrifuged to 
remove the bovine serum albumin solution, resuspended, 
and cultivated with FITC-conjugated R13 (  FITC-R13) 
for 60 minutes at 37°C (approximately 1 × 106 cells and 
0.5 nmol FITC-R13 in 1 mL phosphate-buffered saline 
[PBS]). The cells were washed with 3 mL of 0.01M PBS 
four times and resuspended in PBS to determine the binding 
affinity of R13 to integrin receptor using flow cytometry 
(BD FaCSAria; BD, NJ).
Synthesis of P123-PEI-R13
Synthesis of P123-PEI
Activated P123 should be obtained first in order to prepare 
P123-PEI. P123 (0.6 mmol) was dried by coevapora-
tion with anhydrous toluene in a vacuum at 50°C, then 
dissolved in toluene/dichloromethane (3:1, 40 mL) and 
treated with bis-(trichloromethyl)-carbonate (0.356 g, 
1.2 mmol) overnight. After the solution was evaporated 
to dryness under a vacuum, the residue was redissolved 
in toluene/dechloromethane (2:1, 30 mL) and treated with 
solid N-hydroxysuccinimide (0.240 g, 2.0 mmol), followed 
by anhydrous triethylamine (0.28 mL, 2.0 mmol). After 
4 hours of stirring, the solution was filtered and evaporated 
to dryness. The product was purified on a silica gel column 
using stepwise elution with trichloromethane methanol 
(10%–15%, v/v) mixtures.
LMW PEI (0.20 g, 0.10 mmol) was dissolved in 
10 mL anhydrous dichloromethane as Solution A, and 
the predetermined amount of activated P123 (0.01 mmol) 
was dissolved in 10 mL anhydrous ethanol as Solution B. 
Then, Solution A and Solution B were slowly added to a 
base solution of 10 mL anhydrous dichloromethane with 
constant stirring. The reaction mixture was left overnight 
at room temperature. After completion of reaction, the con-
jugate was dialyzed using Spectra/Por 1 dialysis membrane 
(Spectrum, CA) against distilled water at 4°C for 2 days 
and then lyophilized.
Conjugation of P123-PEI with R13
P123-PEI was conjugated with R13 using SMCC as cross-
linker. After the appropriate amount of SMCC solution 
(3.33 mg/mL in dimethyl sulfoxide) was added dropwise to 
P123-PEI solution (9 mg/mL in 0.1M PBS) at a molar ratio 
of 10:1, 5:1, and 2:1, the reaction mixture was incubated for 
30 minutes at room temperature with gentle shaking. The 
excess nonreacted crosslinker was removed by gel chro-
matography (Sephadex G-25; Pharmacia, Milton Keynes, 
UK). Thus, N-hydroxysuccinimide (NHS) eaters of SMCC 
have reacted with primary amines of P123-PEI to form 
amide bonds and produce the maleimide-activated P123-
PEI. Then, R13 (10 mg/mL in 0.1M PBS) was reacted with 
the maleimide-activated P123-PEI at a molar ratio of 10:1, 
5:1, and 2:1. The reaction mixture was stirred in the dark 
overnight at 4°C and then lyophilized after the nonreacted 
R13 was removed by ultrafiltration with Amicon Ultra-4 
centrifugal filter devices (Millipore, Billerica, MA). Then, 
three types of cationic polymer were obtained and named 
P123-PEI-R13-h, P123-PEI-R13-m, and P123-PEI-R13-l, 
respectively.
Characterizations of P123-PEI-R13  
(NMR, GPC)
A total of 10 mg of P123-PEI and P123-PEI-R13 was 
d  issolved in 0.6 mL of deuterium oxide (D2O) in a nuclear 
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magnetic resonance (NMR) tube, and the 1H NMR spectra 
were recorded using a Varian 300 MHz spectrometer at room 
temperature.
The molecular weight and its distribution of the polymers 
were measured by gel permeation chromatography with 
multiangle laser light scattering (GPC-MALLS) (LC-20 AD; 
Shimadzu, Kyoto, Japan) (690 nm laser wavelength) using 
TSK-GEL G5000PWXL column (temperature 40°C) operated 
at a flow rate of 0.4 mL/minute. Ammonium acetate (0.2M) 
was used as a mobile phase.
Degradation of P123-PEI-R13
Degradation of P123-PEI-R13 was estimated by the mea-
surement of molecular weight. Of the polymers, 0.5 g was 
dissolved in 10 mL of PBS (0.1M, pH = 7.4) and incu-
bated at 37°C with shaking at 100 rpm. After incubation 
for different lengths of time, solutions of the polymers 
were lyophilized and the molecular weights of lyophilized 
samples were measured by GPC-MALLS with 690 nm 
laser wavelength.
Preparation of P123-PEI-R13/DNA 
complexes
Charge ratio (w/w) of P123-PEI-R13/DNA complex was 
expressed as the ratio of the weight of P123-PEI-R13 and 
DNA. Complexes were induced to self-assemble by mixing 
DNA solution with polymer solution (0.1M PBS, pH = 7.4) 
at a desired charge ratio. The complexes were allowed to 
stand at room temperature for 30 minutes.
Measurement of particle size  
and zeta potential
The sizes and zeta potential of polymer/DNA complexes in 
PBS buffer at room temperature were measured using an 
electrophoretic light-scattering spectrophotometer (Zetasizer 
Nano ZS90, MAN0317 Issue 5.0; Malvern Instruments, 
Malvern, UK), with 90° scattering angles. The complexes 
were prepared at desired w/w ratios and incubated at room 
temperature for 30 minutes before the sizes and zeta potential 
measurements were carried out. All the experiments were 
performed in triplicate.
Agarose gel retardation assay
After preparation of polymer/DNA complexes, 10 µL 
of the complex solution (250 ng of plasmid DNA) was 
added to 1 µL of a 10 × loading buffer. The sample was 
electrophoresed on 1% (w/v) agarose gel for 40 minutes 
at 120 V. The gel was stained with ethidium bromide 
(0.5 µg/mL) for about 20 minutes at room temperature 
and illuminated on an ultraviolet illuminator to show the 
location of the DNA.
Resistance to DNase I digestion
Different amounts of DNase I were added to 10 µL of the 
complex solution (250 ng of plasmid DNA) in 0.5 mL 
Eppendorf tubes and incubated at 37°C for 15 minutes. 
Then, 2 µL of 250 mM EDTA solution was added to each 
tube and incubated at room temperature for 10 minutes to 
inactivate DNase I. Next, 10 µL of 2 mg/mL sodium heparin 
was added to each tube and incubated at room temperature 
for 2 hours to dissociate the complex completely. After that, 
the electrophoresis was performed to evaluate the resistance 
of P123-PEI-R13 to DNase I digestion.
Resistance to serum and heparin
A total of 10 µL per tube of the complex solution (250 ng of 
plasmid DNA) was added to 0.5 mL Eppendorf tubes. Dif-
ferent volumes of FBS were added and incubated at 37°C 
for 60 minutes. Similarly, different concentrations of 2 µL 
sodium heparin solution were added to 0.5 mL tubes con-
taining 10 µL of the complex solution and incubated at 37°C 
for 30 minutes. Then, the electrophoresis was performed to 
determine the sensitivity of the polymer/DNA complex to 
serum and heparin.
Cytotoxicity assay
The cytotoxicity of the polymers on the B16 and Hela 
cells was measured using the MTT assay. B16 and Hela 
cells were seeded at a density of 5000 cells per well in 
200 µL of growth medium in 96-well plates and incubated 
for 24 hours to reach 80% confluence. Then, the culture 
medium was replaced with fresh serum-free mediums 
containing serial dilutions of P123-PEI-R13, PEI 2 kDa, 
and PEI 25 kDa at various concentrations (4 µg/mL, 
8 µg/mL, 16 µg/mL, 24 µg/mL, 32 µg/mL, and 48 µg/mL). 
The cells were incubated for another 24 hours before the 
medium was replaced with 180 µL of fresh growth medium 
and 20 µL MTT (5 mg/mL) was added. After 4 hours of 
incubation, unreacted dye was removed by aspiration and 
150 µL of dimethyl sulfoxide was added as a solvent for 
formazan crystals. The absorbance value at 570 nm was 
determined using an ELISA plate reader (Model 680; Bio-
Rad, Hercules, CA). Cell viability was calculated from 
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these data. The cell viability (%) was calculated according 
to the following equation:
Cell viability (%) = (Atest/Acontrol) × 100 
             (mean ± standard deviation, n = 6)
where Atest is the PEI-P123-R13 or PEI-treated cells and Acontrol 
is the absorbance of the untreated cells.
In vitro gene transfection
We examined the ability of P123-PEI-R13 to transfect Hela 
cells and B16 cells using the plasmid pEGFP-N2 and pGL3-
control. The cells were seeded in 24-well plates at a density of 
1 × 105 cells per well in RPMI 1640 medium containing 10% 
FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin, and 
incubated for 18–24 hours to reach 80% confluence. Before 
transfection, the medium was replaced with 450 µL fresh 
RPMI 1640 supplemented with 10% FBS. Then, 50 µL of the 
polymer/DNA complex solution containing 0.8 µg of pDNA 
at various weight ratios ranging from 2 to 30 were added to 
24-well plates and incubated for 4 hours at 37°C in a 5% CO2 
atmosphere. Then, the polymer concentration was calculated 
according to the w/w ratio, and the final volume of culture 
medium per well ranged from 3.2 µg/mL to 48 µg/mL. After 
exchanging with a fresh medium with 10% FBS, cells were 
further incubated for 48 hours. After transfection for 48 hours, 
inverted fluorescent microscope (AE-31, Motic Corporation, 
Wetzlar, Germany) was used to observe the EGFP expression 
of the polyplexes in Hela cells and B16 cells. Then, the cells 
were trypsinized, centrifuged to remove culture medium, 
and resuspended in PBS to determine transfection efficiency 
using flow cytometry (BD FaCSAria). The data analysis was 
performed using the CellQuest software (Becton Dickinson, 
Franklin Lakes, NJ).
The luciferase assay was carried out according to the 
manufacturer’s instructions (Promega, Madison, WI). The 
growth medium was removed, and the cells were shaken for 
30 minutes at room temperature in 200 µL of cell culture lysis 
reagent (CCLR). Luciferase activity was measured with a 
luminometer (Turner Designs Luminometer Model TD-20/20; 
Promega). The relative light units were normalized against 
protein concentration in the cell extracts, which was measured 
using a BCA protein assay kit (Pierce, Rockford, IL).
Results and discussion
Binding of FITC-R13 to αvβ3-positive 
cells
In order to evaluate the specificity of R13 for αvβ3 receptor, 
αvβ3-positive cells (Hela cells and B16 cells) and   αvβ3-negative 
cells (MCF-7 cells) were chosen to   perform comparative 
  experiments. Hela cells, B16 cells, and MCF-7 cells were incu-
bated with FITC-R13 and then analyzed using flow cytometry. 
As is shown in Figure 1, the percentage of positive Hela cells 
and B16 cells is much higher than that of MCF-7 cells. The 
results indicate that R13 showed specificity for αvβ3-positive 
cells in vitro and in Hela cells and B16 cells.
Synthesis and characterization  
of P123-PEI-R13
The degradable PEI derivates of P123-PEI were synthesized 
by linking PEI 2 kDa with P123 and then conjugated with 
a bifunctional peptide R13 to prepare a new nonviral gene 
delivery vector P123-PEI-R13 (Figure 2). As for P123-
PEI, the free hydroxyl groups of P123 were activated by 
succinimidyl carbonate in advance and then linked to the 
amino groups of PEI.21 SMCC was used as crosslinker to 
conjugate P123-PEI with R13. The structures of P123-PEI 
and P123-PEI-R13 were confirmed by 1H NMR spectroscopy 
(  Figure 3). Figure 3A shows the 1H-NMR spectra of P123-PEI 
in D2O, where -CH2CH2O- proton peaks appear at δ3.55 ppm 
and -CH2CH2 NH- proton peaks appear at δ2.51–2.7 ppm. 
  Figure 3B shows the 1H-NMR spectra of P123-PEI-R13 in 
D2O, where the proton peaks move toward the lower mag-
net field as compared with those in Figure 3A, due to the 
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Figure 3 1H- nuclear magnetic resonance spectra of P123-polyethylenimine (PEI) (A) and P123-polyethylenimine-R13 (B) in deuterium oxide at room temperature.
production of groups with electronic screening effect from 
R13, such as the amide group and carbonyl group. At the 
same time, the proton peaks at δ2.51–2.7 ppm applanatus, 
and the peak value at δ1.00 ppm increases, indicating that 
R13 has been coupled to P123-PEI successfully.
Degradation studies
After a nondegradable carrier (eg, PEI 25 kDa) transfers 
pDNA into target cells, it cannot be degraded or eliminated 
from the cells. The intracellular accumulation leads to poten-
tial cytotoxicity. So degradation of gene-delivery polymers 
in vivo is very important for safe gene transfection.22,23 The 
ester bonds of the synthetic P123-PEI-R13 are susceptible to 
hydrolysis at physiological conditions so that the polymer can 
degrade into poloxamer oligomers and LMW PEI, which can 
be secreted to the extracellular environment by exocytosis, and 
shows little toxic effect on cells. The average results of the test 
for in vitro degradation are shown in Figure 4 with standard 
deviation bars. P123-PEI-R13 was degraded slowly and the 
degradation was nearly completed after about 60 hours.
In order to obtain meaningful information for the degrada-
tion model, the degradation profile was fitted to three different 
kinetic models, and the goodness of fit of the degradation 
data was assessed. The degradation profile of P123-PEI-R13 
could be well described by a zero-order model. The half-life 
of P123-PEI-R13 was found to be about 30 hours, according 
to the model.
Particle size and zeta potential 
measurements
The particle size and zeta potential of polymer/DNA com-
plexes were examined at different w/w ratios. As is shown 
in Figure 5, with an increase of polymer/DNA weight ratios 
the particle size decreased. This showed that the polymers 
with more charge could condense DNA more effectively. 
All polymers can concentrate pDNA into nanoparticles, and 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1155
A degradable gene vector of P123-PEI-R13International Journal of Nanomedicine 2012:7
05 10 15 20 25 30 35 40 45
0
5
10
15
20
25
30
35
40
45  P123-PEI-R13-h
 P123-PEI-R13-m
 P123-PEI-R13-l
Z
e
t
a
 
p
o
t
e
n
t
i
a
l
 
(
m
V
)
w/w ratio
Figure 6 Zeta potential (mV) of P123-polyethylenimine (PEI)-R13/DNA complexes 
at various w/w ratios.
Note: The data were expressed as mean values (±standard deviations, n = 3).
01 02 03 04 05 06 0
5,000
10,000
15,000
20,000
25,000
30,000
M
w
Time (h)
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in 0.1 M phosphate-buffered saline (pH = 7.4) and incubated at 37°C and 100 
rpm. Determination of molecular weight (MW) was measured by gel permeation 
chromatography with multiangle laser light scattering (n = 3).
their average particle sizes vary from 100 nm to 250 nm, 
depending on the composition of the complexes, which are 
suitable for efficient gene delivery in vivo.24 In the range of 
concentration studied, no precipitation was observed at any 
w/w ratios.
Positively charged surfaces of the complexes are thought 
to be important for binding to negatively charged cellular 
membranes and cellular uptake via endocytosis.25 However, 
strong cationic charges of the complexes also lead to cyto-
toxicity.21 Figure 6 shows zeta potentials of the complexes 
according to w/w ratio. The zeta potentials of all complexes 
were gradually increased in accordance with the increase 
of charge ratios. At low w/w ratios, the zeta potential of the 
complexes was a slightly positive value. The zeta potentials 
rapidly increased up to w/w ratio 10, whereas they slowly 
increased from w/w ratio 10.
Condensation status of plasmid  
DNA by P123-PEI-R13
The DNA condensation capacity of P123-PEI-R13 was 
determined by gel retardation experiments at various w/w 
ratios. As is shown in Figure 7, the movement of the plasmid 
DNA in the gel is retarded as the amount of the polymers 
increases, demonstrating that the polymers bind to the DNA 
and neutralize its charge. When the w/w ratios of the   polymer 
and DNA exceed the neutralization composition, the com-
plexes will have a positive charge and stop   migrating toward 
the anode. In this experiment, all the polymers of P123-PEI-
R13 were able to condense DNA effectively and neutralized 
its charge at a w/w ratio of 2. Moreover, for unconjugated 
P123-PEI, DNA was retarded at a w/w ratio of 0.4 (data not 
shown). Correspondingly, more P123-PEI-R13 was needed 
to condense pDNA completely than P123-PEI, possibly 
because more primary amines of P123-PEI were substituted 
by R13 so that less positively charged primary amines inter-
acted with negatively charged pDNA phosphates.24
Protection of P123-PEI-R13  
on plasmid DNA
After the complex solution was incubated with DNase I, 
partial DNA was still protected from digestion by DNase I, 
even at a concentration of 6 U DNase I/µg DNA, and was 
released from the complex (Figure 8A). In fact, under the 
same experimental conditions, DNA could be completely 
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Figure 5 Particle sizes (nm) of P123-polyethylenimine (PEI)-R13/DNA complexes 
at various w/w ratios.
Note: The data were expressed as mean values (±standard deviations, n = 3).
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Figure 7 Agarose gel electrophoresis of the complexes at various w/w (P123-polyethylenimine [PEI]-R13/DNA) ratios: (A) P123-PEI-R13-h, (B) P123-PEI-R13-m, and (C) 
P123-PEI-R13-l.
digested by DNase I at a concentration of 0.08 U DNase 
I/µg DNA.26
The stability evaluation of the P123-PEI-R13/DNA 
complex in vivo was simulated by treating the complex with 
serum and sodium heparin in vitro. As is shown in Figure 8B, 
serum cannot dissociate the complex even at a concentration 
of 50%. To infer, the P123-PEI-R13/DNA complex may 
remain stable in blood circulation.
Sodium heparin with a potent negative charge can be 
used to simulate macromolecules carrying negative charges 
in the blood and evaluate the antidissociation ability of a 
vector system in vitro. Sodium heparin can dissociate the 
complexes in a concentration-dependent manner.26 Sodium 
heparin could dissociate the P123-PEI-R13/DNA complexes 
when its concentration was 260 µg/mL at a w/w ratio of 
20:1. The concentration of sodium heparin was more than 
600 µg/mL before complete dissociation of the complexes 
(Figure 8C).
Cytotoxicity assay
There was a correlation between cytotoxicity and molecu-
lar weight. The high-molecular-weight PEI was limited as 
a transfection reagent for its relatively high cytotoxicity. 
Many attempts were made to reduce the cytotoxicity of 
the gene carrier, of which the most favorable one is an 
  introduction of degradable polymer through some link-
ers.23,27–29 Here, the cytotoxicity of the degradable P123-
PEI-R13 was evaluated in Hela cells and B16 cells using 
the MTT assay in comparison with PEI 25 kDa. As is 
shown in Figures 9 and 10, P123-PEI-R13 and PEI 2 KDa 
showed significantly higher cell viability as compared with 
PEI 25 kDa at any concentration (P , 0.01). It is worth-
while noting that P123-PEI-R13 showed low cytotoxicity 
at various concentrations, even at a high concentration, 
indicating that the polymer is very suitable for gene 
  delivery because we can administrate more P123-PEI-R13 
to improve transfection efficiency if necessary.
The lower cytotoxicity may be due to the lower amino 
group density and low toxic building blocks.9,22 As far as 
P123-PEI-R13 is concerned, the ester bonds of the polymer 
can degrade into poloxamer oligomers and LMW PEI at 
physiological conditions, which can be rapidly excluded 
from the cell, then show little cytotoxicity. Meanwhile, the 
amino group density compared with high-molecular-weight 
PEI may also be reduced, resulting in lower cytotoxicity 
to the cells.
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Figure 8 Protection of P123-polyethylenimine (PEI)-R13 on plasmid DNA. (A) Protection of plasmid DNA from degradation by DNase I at varying concentrations of 0 
DNase I/µg DNA, 0.15 DNase I/µg DNA, 0.375 DNase I/µg DNA, 0.75 DNase I/µg DNA, 1.5 DNase I/µg DNA, 2.25 DNase I/µg DNA, 3 DNase I/µg DNA, 3.75 DNase 
I/µg DNA, 4.5 DNase I/µg DNA, 5.25 DNase I/µg DNA, 6 DNase I/µg DNA, 6.75 DNase I/µg DNA, and 7.5 U DNase I/µg DNA. (B) Protection of plasmid DNA from 
dissociation by serum at varying concentrations of 10%, 25%, and 50%. The lanes 10%, 25%, and 50% without “+” refer to the presence of only 10%, 25%, and 50% serum. 
The lanes 10%, 25%, and 50% with “+” refer to the presence of P123-PEI-R13/DNA complexes at w/w ratio 20 with different concentration of serum. (C) Protection of 
plasmid DNA from dissociation by sodium heparin at varying concentrations of 0 µg/mL, 120 µg/mL, 140 µg/mL, 160 µg/mL, 180 µg/mL, 200 µg/mL, 220 µg/mL, 240 µg/mL, 
260 µg/mL, 280 µg/mL, 300 µg/mL, 400 µg/mL, 500 µg/mL, and 600 µg/mL.
In vitro transfection efficiency
As for the pEGFP-N2 reporter gene, transfection efficiency 
of P123-PEI-R13 polymers in Hela and B16 cells is shown 
in Figure 11A and B. In Figure 11A and B, transfection 
efficiency of P123-PEI-R13/DNA complexes increased in 
correlation with the w/w ratio in Hela cells and B16 cells. On 
the whole, the EGFP reporter gene expression in Hela cells 
exceeded that in B16 cells, showing that the gene transfection 
was selective to cells. Representative fluorescence images 
for the transfection of Hela cells and B16 cells using P123-
PEI-R13 at the optimal conditions are shown in Figure 11C. 
The microscopic images in a bright field of nontransfected 
cells and transfected cells are included in Figure 11D. The 
transfection of P123-PEI-R13/DNA complexes did not alter 
the morphology of the cells, indicating that P123-PEI-R13 
was suitable for gene delivery.
Figure 12 shows the results of the gene transfection 
efficiency of P123-PEI-R13/pGL3-control complexes in 
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Figure 9 Cytotoxicity of P123-polyethylenimine (PEI)-R13 at various concentrations in Hela cell lines using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide assay.
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Figure 10 Cytotoxicity of P123-polyethylenimine (PEI)-R13 at various concentrations in B16 cell lines using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium 
bromide assay.
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Hela cells in comparison with P123-PEI and PEI 2 KDa 
polyplexes. The P123-PEI-R13-h, P123-PEI-R13-m, and 
P123-PEI-R13-l polyplexes exhibited the maximal transfec-
tion efficiency at the weight ratio of 30. Based on cytotoxicity 
assay, the cell viability was over 85% at the w/w (polymer/
DNA) ratio of 30. All synthesized P123-PEI-R13 showed 
much higher gene transfer ability compared with PEI 2 KDa, 
and the highest luciferase expression level obtained at P123-
PEI-R13-l was more than 230 times higher compared with 
that of PEI 2 KDa, and even about two times higher than PEI 
25 KDa at the optimal conditions (w/w = 0.8, data not shown). 
It should be noted that the bifunctional R13 peptide not 
only could make the P123-PEI-R13/DNA complexes target 
the cells but also could promote cargo transport. Therefore, 
the P123-PEI-R13/DNA complexes showed about 34 times 
higher gene transfection than P123-PEI/DNA complexes at 
optimal conditions. In addition, transfection efficiency of 
P123-PEI-R13 decreased with an increase of the R13 rate, 
which can be explained by the high modification degree of 
R13 leading to a less positive surface. Figure 13 shows the 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1159
A degradable gene vector of P123-PEI-R13International Journal of Nanomedicine 2012:7
    
A
P123-PEI-R13-h, hela cells                  P123-PEI-R13-h, B16 cells 
P123-PEI-R13-m, hela cells                  P123-PEI-R13-m, B16 cells 
51 02 03 0
0
10
20
30
40
50
60
G
F
P
 
e
x
p
r
e
s
s
i
o
n
 
(
%
)
w/w ratio
 P123-PEI-R13-h
 P123-PEI-R13-m
 P123-PEI-R13-l
C
P123-PEI-R13-l, hela cells                  P123-PEI-R13-l, B16 cells 
51 02 03 0
0
10
20
30
G
F
P
 
e
x
p
r
e
s
s
i
o
n
 
(
%
)
w/w ratio
 P123-PEI-R13-h
 P123-PEI-R13-m
 P123-PEI-R13-l
D
B
Non-transfected hela cells                  Non-transfected B16 cells
Transfected hela cells                      Transfected B16 cells
Figure 11 Green fluorescent protein (GFP) reporter gene transfection in Hela cells and B16 cells by P123-polyethylenimine (PEI)-R13. (A) Percentage of GFP transfection in 
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Figure 13 Transfection efficiency of different polymer/DNA complexes at B16 cell line.
Notes: Each data point represents the mean ± standard deviation; n = 6, **P , 0.01.
Abbreviations: PEI, polyethylenimine; RLU, relative light unit.
results of the gene transfection efficiency of P123-PEI-R13/
pGL3-control complexes in B16 cells in comparison with 
P123-PEI and PEI 2 KDa polyplexes. The P123-PEI-R13-h, 
P123-PEI-R13-m, and P123-PEI-R13-l polyplexes exhibited 
the maximal transfection efficiency at the weight ratio of 20, 
10, and 10, respectively. Accordingly, the cell viabilities were 
75.73% ± 2.81%, 92.84% ± 8.06%, and 96.40% ± 2.41%, 
based on cytotoxicity assay. Similar to the transfection of 
P123-PEI-R13 polyplexes in Hela cells, they also showed 
much higher gene transfection than P123-PEI, PEI 2 KDa, 
and PEI 25 KDa polyplexes at optimal conditions.
Conclusion
We developed a new nonviral gene vector, PEI-P123-R13, 
by crosslinking LMW PEI with P123 and further coupled a 
bifunctional peptide R13 to the polymer for targeting tumor 
and increasing cellular uptake. Through various physico-
chemical methods, we confirmed that PEI-P123-R13 had the 
ability to form complexes with DNA and suitable physico-
chemical properties for gene delivery. Furthermore, the new 
gene vector showed much lower cytotoxicity and higher gene 
transfection efficiency compared with PEI 25 kDa in two 
different cell lines (Hela and B16). In conclusion, this new 
polymer might be a potential candidate in gene delivery with 
low cytotoxicity and high transfection efficiency. However, 
it is worth investigating whether PEI-P123-R13 can exhibit 
the same excellent properties such as cyclical stability, tumor 
targeting, noncytotoxicity, and effective transfection in vivo. 
Also, the delivery of therapeutic genes mediated by this gene 
vector and the therapeutic efficiency need to be studied in 
animal models. We are currently conducting more compre-
hensive studies with the aim to answer these questions. We 
will present our findings in another manuscript.
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